Palasis Maria
SEC Form 4 insider trading activity
Palasis Maria has filed 6 SEC Form 4 filings (8 transaction rows) across 2 companies, including BBNX, LYRA, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 26, 2026.
On the most recent filing, Palasis Maria is listed as President & CEO at Lyra Therapeutics, Inc. Inside the rolling window, Palasis Maria reported no open-market purchases and 3 open-market sales totaling $85K in LYRA and BBNX. The largest disclosed transaction in the window is a sale of 1,406 BBNX shares on Dec 1, 2025, worth $42K.
Companies traded
Other insiders at BBNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$85K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Palasis Maria made?
Palasis Maria has filed 6 SEC Form 4 filings (8 transaction rows) across 2 companies, including BBNX, LYRA since 2025.
Which companies does Palasis Maria trade?
Palasis Maria has filed SEC Form 4 disclosures for 2 companies, including BBNX, LYRA.
When was Palasis Maria's most recent SEC Form 4 filing?
Palasis Maria's most recent SEC Form 4 filing on Tracefour is dated May 26, 2026.
What is Palasis Maria's total buy and sell value in the current window?
Inside the rolling retention window, Palasis Maria bought $0 and sold $85K based on SEC Form 4 filings.
What was Palasis Maria's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,406 BBNX shares on 2025-12-01, worth $42K, per SEC Form 4 filings.